Register
FDA Watch List Adds Drugs with Anaphylaxis, Herpes, Fetal Death Risk |
News and Updates
eMediNexus Coverage from: 
FDA Watch List Adds Drugs with Anaphylaxis, Herpes, Fetal Death Risk
eMediNexus,  30 October 2019
remove_red_eye 520 Views
#Allergy and Immunology #Dermatology #Infectious Diseases #Pathology and Lab Medicine #Pharmacist

0 Read Comments                

The US Food and Drug Administration (FDA) has updated its quarterly watch list with four dozen drugs and drug classes because it has received new safety information or identified possible signs of serious risk — including serious risks from conditions such as anaphylaxis, herpes zoster, and fetal death.

Six drugs/drug classes were added to the list for potential risk of fetal death. They were ferumoxytol (Feraheme); sodium ferric gluconate (Ferrlecit); iron dextran (INFeD); ferric carboxymaltose (Injectafer); iron sucrose (Venofer); and generic products containing sodium ferric gluconate… (Medscape)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now